Multiple sclerosis (MS) is a chronic neurological disorder affecting the central nervous system (CNS), particularly the brain ...

LONDON, Nov 13 (Reuters) - Britain's Financial Conduct Authority (FCA) on Wednesday softened proposals to publicly name some ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Schrodinger (SDGR) today announced a research collaboration and license agreement with Novartis (NVS) to advance multiple development ...

"We're still in discussions with the (UK) government to figure out what type of incentives there may be. We don't have ...

Hidradenitis suppurativa (HS) is a relatively common skin disease, affecting as many as one percent of people worldwide. But ...

Novartis (NVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Scala from ...

The UK Government recently announced a new public-private collaboration to develop the world's first early warning system for ...

Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the Topical Drug ...

In a statement to Windows Central, Microsoft has confirmed that it's unifying its news content services under the MSN brand once again.

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...